Antigen processing genes in the responsiveness to interferon therapy in the patients with chronic hepatitis C.

被引：0
|
作者：
Kikuchi, I [1 ]
Mihara, K [1 ]
Miyanaga, O [1 ]
Machidori, H [1 ]
Ishikawa, E [1 ]
Ueda, A [1 ]
机构：
[1] Miyazaki Prefectural Hosp, Dept Internal Med, Miyazaki, Japan
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1642
引用
收藏
页码：573A / 573A
页数：1
相关论文
共 50 条
  • [1] Transporter associated with antigen processing (TAP) 2 gene polymorphisms in the responsiveness to interferon therapy in the patients with chronic hepatitis C.
    Kikuchi, I
    Mihara, K
    Miyanaga, O
    Ishikawa, E
    Jingu, N
    Ueda, A
    HEPATOLOGY, 1999, 30 (04) : 261A - 261A
  • [2] HLA alleles and glucose intolerance in the responsiveness to interferon therapy in the patients with chronic hepatitis C.
    Kikuchi, I
    Ueda, A
    Mihara, K
    Miyanaga, O
    Machidori, H
    Ishikawa, E
    Tamura, K
    HEPATOLOGY, 1997, 26 (04) : 726 - 726
  • [3] Effect of transporter associated with antigen processing (TAP) genes to interferon therapy in patients with chronic hepatitis C: Heterozygote advantage
    Kikuchi, I
    Mihara, K
    Ishikawa, E
    Jingu, N
    Ueda, A
    GASTROENTEROLOGY, 2002, 122 (04) : A644 - A644
  • [4] Immunogenetic analysis of the responsiveness to interferon therapy in the patients with chronic hepatitis C
    Kikuchi, I
    Ueda, A
    Mihara, K
    Miyanaga, O
    Machidori, H
    Tamura, K
    GASTROENTEROLOGY, 1996, 110 (04) : A1232 - A1232
  • [5] Associations of CTLA-4 gene polymorphisms with responsiveness to interferon therapy in patients with chronic hepatitis C.
    Kikuchi, I
    Mihara, K
    Miyanaga, O
    Ishikawa, E
    Jingu, N
    Ueda, A
    HEPATOLOGY, 2000, 32 (04) : 371A - 371A
  • [6] Combination therapy with interferon α and β to chronic hepatitis C.
    Horilke, N
    Michitaka, K
    Masumoto, T
    Yamamoto, K
    Yamauchi, Y
    Kojima, N
    Onjl, M
    HEPATOLOGY, 1998, 28 (04) : 373A - 373A
  • [7] Prediction of responsiveness to interferon therapy with a new test for hepatitis C virus genotype and viral load determination in patients with chronic hepatitis C.
    Fukuda, Y
    Nakano, I
    Katano, Y
    Toyoda, H
    Yokozaki, S
    Hayashi, K
    HEPATOLOGY, 2002, 36 (04) : 593A - 593A
  • [8] Induction therapy with consensus interferon in the treatment of patients with chronic hepatitis C.
    Kwo, PY
    Fields, S
    Chalasani, N
    Cho, W
    Crabb, DW
    Cummings, OW
    Imperiale, TF
    Lumeng, L
    McGill, JM
    Ness, RM
    Pintozzi, R
    Jones, B
    Lansford, C
    Maier, J
    Isenberg, M
    Mark, D
    Bennet, C
    Noar, M
    McCone, J
    Chasen, R
    Geissinger, B
    Goldstein, M
    Thuluvath, P
    GASTROENTEROLOGY, 2000, 118 (04) : A1460 - A1460
  • [9] Estimating the benefit of interferon therapy for individual patients with chronic hepatitis C.
    Yoshida, H
    Tateishi, R
    Arakawa, Y
    Sata, M
    Nishiguchi, S
    Ishibashi, H
    Fujiyama, S
    Yamada, G
    Yokosuka, O
    Shiratori, Y
    Omata, M
    HEPATOLOGY, 2003, 38 (04) : 641A - 641A
  • [10] Interferon retreatment of patients with chronic hepatitis C.
    Picciotto, A
    Campo, N
    Brizzolara, R
    Sinelli, N
    GiudiciCipriani, A
    Ponassi, I
    Varagona, G
    Grasso, A
    DeLeo, P
    DeConca, V
    Mesiti, S
    Marenco, G
    Menardo, G
    Dodero, M
    Celle, G
    HEPATOLOGY, 1997, 26 (04) : 1160 - 1160
12345